Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-12 Sale | 2026-01-14 4:22 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 2,780 | $362.87 | $1,008,766 | 57,522 (Indirect Direct) | View |
| 2025-10-02 Sale | 2025-10-03 5:14 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 3,821 | $452.05 | $1,727,284 | 54,109 (Indirect Direct) | View |
| 2025-08-18 Sale | 2025-08-19 5:27 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 2,274 | $453.27 | $1,030,727 | 50,178 (Indirect Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:21 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,264 | $243.78 | $308,141 | 57,608 (Indirect Direct) | View |
| 2025-02-28 Sale | 2025-03-03 4:31 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 796 | $241.7 | $192,390 | 35,863 (Indirect Direct) | View |
| 2025-02-14 Sale | 2025-02-18 4:47 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 967 | $255.17 | $246,750 | 32,843 (Indirect Direct) | View |
| 2024-11-26 Sale | 2024-11-27 5:21 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,682 | $250.98 | $422,144 | 30,701 (Indirect Direct) | View |
| 2024-06-25 Sale | 2024-06-26 4:26 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,605 | $231 | $370,747 | 28,949 (Indirect Direct) | View |
| 2024-02-28 Sale | 2024-02-29 4:18 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 574 | $155.3 | $89,145 | 23,351 (Indirect Direct) | View |
| 2024-02-16 Sale | 2024-02-20 4:08 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,007 | $148.06 | $149,099 | 18,201 (Indirect Direct) | View |
| 2023-08-04 Sale | 2023-08-07 6:05 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 3,460 | $185.85 | $643,037 | 15,930 (Indirect Direct) | View |
| 2023-04-27 Sale | 2023-04-28 5:55 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 977 | $194.59 | $190,113 | 11,763 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-11 Option Award | 2026-01-14 4:22 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 6,193 | $0 | 57,522 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 5:14 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 7,752 | $0 | 54,109 (Direct) | View |
| 2025-08-15 Option Award | 2025-08-19 5:27 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 4,644 | $0 | 50,178 (Direct) | View |
| 2025-06-23 Option Award | 2025-06-25 5:01 pm | N/A 2035-06-23 | CervoMed Inc. | CRVO | Poulton Jeffrey V. Director | 8,100 | $0 | 8,100 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 4:21 pm | N/A 2035-03-03 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 24,917 | $0 | 57,608 (Direct) | View |
| 2025-02-27 Exercise | 2025-03-03 4:31 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,908 | $0 | 35,863 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-18 4:47 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 3,109 | $0 | 32,843 (Direct) | View |
| 2024-11-25 Option Award | 2024-11-27 5:21 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 3,434 | $0 | 30,701 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-26 4:26 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 3,278 | $0 | 28,949 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-14 6:21 pm | N/A 2034-06-14 | CervoMed Inc. | CRVO | Poulton Jeffrey V. Director | 5,750 | $0 | 5,750 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 4:21 pm | N/A 2034-03-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 22,859 | $0 | 42,394 (Direct) | View |
| 2024-02-27 Exercise | 2024-02-29 4:18 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,908 | $0 | 23,351 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 4:08 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 3,278 | $0 | 18,201 (Direct) | View |
| 2023-09-15 Option Award | 2023-09-15 6:52 pm | N/A 2033-09-15 | CervoMed Inc. | CRVO | Poulton Jeffrey V. Director | 6,450 | $0 | 6,450 (Direct) | View |
Ownership | 2023-08-23 9:48 pm | N/A 2028-05-29 | CervoMed Inc. | CRVO | Poulton Jeffrey V. Director | 0 | $0 | 14,963 (Direct) | View |
| 2023-08-03 Option Award | 2023-08-07 6:05 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 7,627 | $0 | 15,930 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 6:09 pm | N/A 2033-06-14 | Homology Medicines Inc. | FIXX | Poulton Jeffrey V. Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2023-04-26 Option Award | 2023-04-28 5:55 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 3,277 | $0 | 11,763 (Direct) | View |
| 2023-02-27 Option Award | 2023-03-01 4:21 pm | N/A 2026-02-27 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 17,574 | $0 | 17,574 (Direct) | View |
| 2022-08-03 Option Award | 2022-08-05 4:14 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 11,325 | $0 | 9,463 (Direct) | View |
| 2022-08-04 Tax Withholding | 2022-08-05 4:14 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 146 | $209.88 | 9,463 (Direct) | View |
| 2022-08-04 Tax Withholding | 2022-08-05 4:14 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 4,573 | $189.76 | 9,463 (Direct) | View |
| 2022-08-04 Tax Withholding | 2022-08-05 4:14 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 173 | $210.5 | 9,463 (Direct) | View |
| 2022-08-04 Tax Withholding | 2022-08-05 4:14 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 162 | $209.83 | 9,463 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:05 pm | N/A 2032-06-15 | Homology Medicines Inc. | FIXX | Poulton Jeffrey V. Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-02-23 Option Award | 2022-02-25 4:12 pm | N/A 2032-02-22 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 18,413 | $0 | 18,413 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-22 5:39 pm | N/A 2031-06-17 | Homology Medicines Inc. | FIXX | Poulton Jeffrey V. Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2021-02-24 Option Award | 2021-02-26 4:04 pm | N/A 2031-02-23 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. Chief Financial Officer | 23,200 | $0 | 23,200 (Direct) | View |